Reported covered position: Legislative Assistant, Rep. Jim Greenwood
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224; S.3353/ HR 5534: The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2025 · fourth_quarter · 4@
newborn screening, prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2025 · fourth_quarter · 4T
Source: Senate LDA
| STRIVE HEALTH |
| 6 |
| 2023–2024 |
| US RENAL CARE | 6 | 2023–2024 |
| BIOMARIN | 4 | 2020 |
| RAPTOR PHARMACEUTICAL CORP. | 4 | 2014 |
| TEMPLE UNIVERSITY | 4 | 2020–2021 |
| AMERICAN DIETETIC ASSOCIATION | 3 | 2009 |
| EVERGREEN NEPHROLOGY | 3 | 2023 |
| PANORAMIC HEALTH | 3 | 2023 |
| VIROPHARMA | 3 | 2013 |
| PERSONALIZED MEDICINE COALITION | 2 | 2019 |
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224; S.3353/ HR 5534: The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224; S.3353/ HR 5534: The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224; S.3353/ HR 5534: The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224; S.3353/ HR 5534: The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224; S.3353/ HR 5534: The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224; S.3353/ HR 5534: The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224; S.3353/ HR 5534: The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: HORIZON GOVERNMENT AFFAIRS
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 212st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies.
Medicare Drug Savings Act of 2011
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Independent Payment Advisory Board, HR 2190 Medicare Drug Savings Act of 2011
Patients' Freedom to Choose Act
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Health Care Reform, H.R. 3590, H.R. 4872; FSA's, HSA's - S. 3673, Patients' Freedom to Choose Act; Rule on Grandfathered health plans - S.J.Res. 39, Enzi Disapproval Resolution
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule relating to status as a grandfathered health plan under the Patient Protection and Affordable Care Act.
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Health Care Reform, H.R. 3590, H.R. 4872; FSA's, HSA's - S. 3673, Patients' Freedom to Choose Act; Rule on Grandfathered health plans - S.J.Res. 39, Enzi Disapproval Resolution
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMICUS THERAPEUTICS, INC. · Firm: HORIZON GOVERNMENT AFFAIRS
Therapeutic tax credit provisions of H.R. 3590
American Middle Class Tax (AMT) Relief Act of 2007
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Health Care Reform, H.R. 3590, H.R. 4872; FSA's, HSA's - S. 3673, Patients' Freedom to Choose Act; Rule on Grandfathered health plans - S.J.Res. 39, Enzi Disapproval Resolution
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMICUS THERAPEUTICS, INC. · Firm: HORIZON GOVERNMENT AFFAIRS
Implementation of therapeutic tax credit provisions of H.R. 3590, the "Patient Protection and Affordable Care Act."
American Middle Class Tax (AMT) Relief Act of 2007
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Health care reform, H.R. 3590, H.R. 4872.
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMICUS THERAPEUTICS, INC. · Firm: HORIZON GOVERNMENT AFFAIRS
Therapeutic discovery tax credit provisions of H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Health care reform, H.R. 3590, H.R. 4872.
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Health care reform, H.R. 3590, H.R. 4872.
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Health care reform, H.R. 3590, H.R. 4872.
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Health Care Reform, H.R. 3590, H.R. 4872; FSA's, HSA's - S. 3673, Patients' Freedom to Choose Act; Rule on Grandfathered health plans - S.J.Res. 39, Enzi Disapproval Resolution
Equity for Our Nation's Self-Employed Act of 2009
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Support for H.R. 1470, "Equity for Our Nation's Self-Employed Act of 2009."
Equity for Our Nation's Self-Employed Act of 2009
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Support for H.R. 1470, "Equity for Our Nation's Self-Employed Act of 2009."
Equity for Our Nation's Self-Employed Act of 2009
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Support for H.R. 1470, "Equity for Our Nation's Self-Employed Act of 2009."
Equity for Our Nation's Self-Employed Act of 2009
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Support for H.R. 1470, "Equity for Our Nation's Self-Employed Act of 2009."
America's Affordable Health Choices Act of 2009
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Ensuring the affordability of health insurance. Health insurance provisions in H.R. 3200, "America's Affordable Health Choices Act of 2009" and S. ____, "America's Healthy Future Act." Funding for State High Risk Pool programs.
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN DIETETIC ASSOCIATION · Firm: HORIZON GOVERNMENT AFFAIRS
Health care reform, H.R. 3590, "Patient Protection and Affordable Care Act."
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN DIETETIC ASSOCIATION · Firm: HORIZON GOVERNMENT AFFAIRS
Medicare coverage of nutrition therapy and prevention and wellness initiatives in H.R. 3962, "Affordable Health Care for America Act," and H.R. 3590, "Patient Protection and Affordable Care Act."
American Middle Class Tax (AMT) Relief Act of 2007
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Ensuring the affordability of health insurance. Health insurance provisions in H.R. 3962, "Affordable Health Care for America Act," and H.R. 3590, "Patient Protection and Affordable Care Act." Funding for State High Risk Pool programs.
Superfund Polluter Pays Act
Client: AMERICAN DIETETIC ASSOCIATION · Firm: HORIZON GOVERNMENT AFFAIRS
Medicare coverage of nutrition therapy and prevention and wellness initiatives in H.R. 3962, "Affordable Health Care for America Act," and H.R. 3590, "Patient Protection and Affordable Care Act."
Superfund Polluter Pays Act
Client: COUNCIL FOR AFFORDABLE HEALTH COVERAGE · Firm: HORIZON GOVERNMENT AFFAIRS
Ensuring the affordability of health insurance. Health insurance provisions in H.R. 3962, "Affordable Health Care for America Act," and H.R. 3590, "Patient Protection and Affordable Care Act." Funding for State High Risk Pool programs.
newborn screening, prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2025 · third_quarter · Q3
newborn screening, prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2025 · second_quarter · Q2
newborn screening, prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2025 · first_quarter · Q1
newborn screening, prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
US RENAL CARE via HORIZON GOVERNMENT AFFAIRS
2024 · fourth_quarter · Q4
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
STRIVE HEALTH via HORIZON GOVERNMENT AFFAIRS
2024 · fourth_quarter · Q4
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERWELL HEALTH via HORIZON GOVERNMENT AFFAIRS
2024 · fourth_quarter · Q4
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DAVITA, INC. via HORIZON GOVERNMENT AFFAIRS
2024 · fourth_quarter · Q4
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2024 · fourth_quarter · Q4
newborn screening, prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
US RENAL CARE via HORIZON GOVERNMENT AFFAIRS
2024 · third_quarter · Q3
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
STRIVE HEALTH via HORIZON GOVERNMENT AFFAIRS
2024 · third_quarter · Q3
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
INTERWELL HEALTH via HORIZON GOVERNMENT AFFAIRS
2024 · third_quarter · Q3
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
DAVITA, INC. via HORIZON GOVERNMENT AFFAIRS
2024 · third_quarter · Q3
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2024 · third_quarter · Q3
newborn screening, prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
US RENAL CARE via HORIZON GOVERNMENT AFFAIRS
2024 · second_quarter · Q2
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
STRIVE HEALTH via HORIZON GOVERNMENT AFFAIRS
2024 · second_quarter · Q2
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
INTERWELL HEALTH via HORIZON GOVERNMENT AFFAIRS
2024 · second_quarter · Q2
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
DAVITA, INC. via HORIZON GOVERNMENT AFFAIRS
2024 · second_quarter · Q2
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2024 · second_quarter · Q2
newborn screening, prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2024 · first_quarter · Q1
newborn screening, health equity and prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
US RENAL CARE via HORIZON GOVERNMENT AFFAIRS
2023 · fourth_quarter · Q4
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
STRIVE HEALTH via HORIZON GOVERNMENT AFFAIRS
2023 · fourth_quarter · Q4
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
PANORAMIC HEALTH via HORIZON GOVERNMENT AFFAIRS
2023 · fourth_quarter · Q4
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
INTERWELL HEALTH via HORIZON GOVERNMENT AFFAIRS
2023 · fourth_quarter · Q4
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
EVERGREEN NEPHROLOGY via HORIZON GOVERNMENT AFFAIRS
2023 · fourth_quarter · Q4
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
DAVITA, INC. via HORIZON GOVERNMENT AFFAIRS
2023 · fourth_quarter · Q4
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2023 · fourth_quarter · Q4
newborn screening, health equity and prescription drug affordability, FDA foreign inspection obligations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
US RENAL CARE via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · Q3
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
STRIVE HEALTH via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · Q3
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
PANORAMIC HEALTH via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · Q3
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
INTERWELL HEALTH via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · Q3
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
EVERGREEN NEPHROLOGY via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · Q3
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
DAVITA, INC. via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · Q3
Medicare provider reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
US RENAL CARE via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · RR
Medicare provider reimbursement issues
STRIVE HEALTH via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · RR
Medicare provider reimbursement issues
PANORAMIC HEALTH via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · RR
Medicare provider reimbursement issues
INTERWELL HEALTH via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · RR
Medicare provider reimbursement issues
EVERGREEN NEPHROLOGY via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · RR
Medicare provider reimbursement issues
DAVITA, INC. via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · RR
Medicare provider reimbursement issues
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2023 · third_quarter · Q3
newborn screening, health equity and prescription drug affordability, FDA foreign inspection obligations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2023 · second_quarter · Q2
newborn screening, health equity and prescription drug affordability, FDA foreign inspection obligations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2023 · first_quarter · Q1
newborn screening, health equity and prescription drug affordability, FDA foreign inspection obligations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2022 · fourth_quarter · Q4
newborn screening, health equity and prescription drug affordability, FDA foreign inspection obligations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2022 · third_quarter · Q3
newborn screening, health equity and prescription drug affordability, FDA foreign inspection obligations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2022 · second_quarter · Q2
newborn screening, health equity and prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2022 · first_quarter · Q1
newborn screening, health equity and prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2021 · fourth_quarter · Q4
newborn screening, health equity and prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2021 · third_quarter · Q3
newborn screening, health equity and prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPLE UNIVERSITY via HORIZON GOVERNMENT AFFAIRS
2021 · second_quarter · 2T
Telehealth, Maternal Health, Minority Health Issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2021 · second_quarter · Q2
newborn screening, health equity and prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPLE UNIVERSITY via HORIZON GOVERNMENT AFFAIRS
2021 · first_quarter · Q1
Telehealth, Maternal Health, Minority Health Issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2021 · first_quarter · Q1
newborn screening, health equity and prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMARIN via HORIZON GOVERNMENT AFFAIRS
2020 · fourth_quarter · Q4
Drug pricing; value-based arrangements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPLE UNIVERSITY via HORIZON GOVERNMENT AFFAIRS
2020 · fourth_quarter · Q4
Telehealth, Maternal Health, Minority Health Issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL KIDNEY FOUNDATION via HORIZON GOVERNMENT AFFAIRS
2020 · fourth_quarter · Q4
Working to extend Medicare drug coverage of immunosuppressant coverage for kidney transplant recipients.
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224; S.3353/ HR 5534: The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2020 · fourth_quarter · Q4
Newborn screening; prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPLE UNIVERSITY via HORIZON GOVERNMENT AFFAIRS
2020 · fourth_quarter · RR
telehealth, maternal health, minority health issues
BIOMARIN via HORIZON GOVERNMENT AFFAIRS
2020 · third_quarter · Q3
Drug pricing; value-based arrangements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via HORIZON GOVERNMENT AFFAIRS
2020 · third_quarter · Q3
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224; S.3353/ HR 5534: The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act.
Working to extend Medicare drug coverage of immunosuppressant coverage for kidney transplant recipients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2020 · third_quarter · Q3
Newborn screening; prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via HORIZON GOVERNMENT AFFAIRS
2020 · second_quarter · Q2
Working to extend Medicare drug coverage of immunosuppressant coverage for kidney transplant recipients.
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2020 · second_quarter · Q2
Newborn screening; prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMARIN via HORIZON GOVERNMENT AFFAIRS
2020 · second_quarter · Q2
Drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMARIN via HORIZON GOVERNMENT AFFAIRS
2020 · first_quarter · Q1
Drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2020 · first_quarter · Q1
Newborn screening; prescription drug affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via HORIZON GOVERNMENT AFFAIRS
2020 · first_quarter · Q1
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Working to extend Medicare drug coverage of immunosuppressant coverage for kidney transplant recipients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2019 · fourth_quarter · Q4
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via HORIZON GOVERNMENT AFFAIRS
2019 · fourth_quarter · Q4
Working to extend Medicare drug coverage of immunosuppressant coverage for kidney transplant recipients.
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2019 · third_quarter · Q3
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via HORIZON GOVERNMENT AFFAIRS
2019 · third_quarter · Q3
Working to extend Medicare drug coverage of immunosuppressant coverage for kidney transplant recipients.
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via HORIZON GOVERNMENT AFFAIRS
2019 · second_quarter · Q2
Working to extend Medicare drug coverage of immunosuppressant coverage for kidney transplant recipients.
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease. The Living Donor Protection Act bill numbers are S.511/HR 1224.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PERSONALIZED MEDICINE COALITION via HORIZON GOVERNMENT AFFAIRS
2019 · second_quarter · Q2
Working to establish personalized medicine caucus
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2019 · second_quarter · Q2
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via HORIZON GOVERNMENT AFFAIRS
2019 · first_quarter · 1A
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PERSONALIZED MEDICINE COALITION via HORIZON GOVERNMENT AFFAIRS
2019 · second_quarter · RR
Working to establish a personalized medicine caucus
NATIONAL KIDNEY FOUNDATION via HORIZON GOVERNMENT AFFAIRS
2019 · first_quarter · Q1
Promoting policies that increase the number of living donors and ensuring patient access to care that improves outcomes for patients with kidney disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2019 · first_quarter · Q1
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via HORIZON GOVERNMENT AFFAIRS
2019 · first_quarter · RA
Advance policy priorities on behalf of kidney patients while positioning NKF as the leading advocacy organization representing kidney patients.
NATIONAL KIDNEY FOUNDATION via HORIZON GOVERNMENT AFFAIRS
2019 · first_quarter · RR
Advance policy priorities on behalf of kidney patients while positioning NKF as the leading advocacy organization representing kidney patients.
PROTHENA BIOSCIENCES INC via HORIZON GOVERNMENT AFFAIRS
2018 · fourth_quarter · Q4
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2018 · fourth_quarter · Q4
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROTHENA BIOSCIENCES INC via HORIZON GOVERNMENT AFFAIRS
2018 · third_quarter · Q3
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2018 · third_quarter · Q3
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROTHENA BIOSCIENCES INC via HORIZON GOVERNMENT AFFAIRS
2018 · second_quarter · Q2
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2018 · second_quarter · Q2
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROTHENA BIOSCIENCES INC via HORIZON GOVERNMENT AFFAIRS
2018 · first_quarter · Q1
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2018 · first_quarter · Q1
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES
PROTHENA BIOSCIENCES INC via HORIZON GOVERNMENT AFFAIRS
2017 · fourth_quarter · Q4
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2017 · fourth_quarter · Q4
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES
PROTHENA BIOSCIENCES INC via HORIZON GOVERNMENT AFFAIRS
2017 · third_quarter · Q3
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2017 · third_quarter · Q3
21st Century Cures Implementation
Filing targets: HOUSE OF REPRESENTATIVES
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2017 · second_quarter · Q2
Prescription Drug User Fee Act (PDUFA)
Filing targets: HOUSE OF REPRESENTATIVES
PROTHENA BIOSCIENCES INC via HORIZON GOVERNMENT AFFAIRS
2017 · second_quarter · Q2
Prescription Drug User Fee Act
Filing targets: HOUSE OF REPRESENTATIVES
PROTHENA BIOSCIENCES INC via HORIZON GOVERNMENT AFFAIRS
2017 · first_quarter · Q1
Prescription Drug User Fee Act
Filing targets: HOUSE OF REPRESENTATIVES
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2017 · first_quarter · Q1
Prescription Drug User Fee Act (PDUFA)
Filing targets: HOUSE OF REPRESENTATIVES
PROTHENA BIOSCIENCES INC via HORIZON GOVERNMENT AFFAIRS
2017 · first_quarter · Q1
Prescription Drug User Fee Act
Filing targets: HOUSE OF REPRESENTATIVES
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2017 · first_quarter · Q1
Prescription Drug User Fee Act (PDUFA)
Filing targets: HOUSE OF REPRESENTATIVES
PROTHENA BIOSCIENCES INC via HORIZON GOVERNMENT AFFAIRS
2016 · fourth_quarter · Q4
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
Filing targets: HOUSE OF REPRESENTATIVES
AMICUS THERAPEUTICS, INC. via HORIZON GOVERNMENT AFFAIRS
2016 · fourth_quarter · Q4
H.R. 6, 21st Century Cures - better innovation, development and delivery of patient therapies
Filing targets: HOUSE OF REPRESENTATIVES